NLS PHARMACEUTICS LTD (NLSP)

CH0523961370 - Common Stock

0.125  -0.01 (-3.99%)

After market: 0.1312 +0.01 (+4.96%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-6-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
14.35M15.48M11.86M2.30M4.20M
Research and Development
7.81M8.98M5.92M100.00K1.70M
Selling, General, and Administrative Expenses
6.53M6.51M5.94M2.20M2.49M
Operating Income
-14.35M-15.48M-11.86M-2.30M-4.20M
Interest Income/Expense
-80.13K-90.00K-90.00K-560.00K-890.00K
Other Income/Expense
-123.13KN/AN/AN/AN/A
Non Recurring Items
N/A-920.00K0.000.00-360.00K
Income Before Taxes
-15.46M-16.50M-11.95M-2.86M-5.45M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-15.46M-16.50M-11.95M-2.86M-5.45M
EBITDA
N/A-15.47M-11.85MN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-0.53-0.84-1.00-0.24-0.46
 
Statistics

All data in USD

Charts